Collaboration on Neurometabolomics Research Annpinced

Agilent Technologies Inc and the Daegu Gyeongbuk Institute of Science and Technology today announced a strategic collaboration with the opening of the DGIST’s new Neurometabolomics Excellence Research Center. The centre will use Agilent’s bio-analytical instruments in its neurometabolomics research of biomarkers for early detection and diagnosis of brain diseases.  

DGIST is one of Korea’s foremost universities and research institutions.

At the new centre, scientists and researchers will analyse changes in the metabolic materials of brain cells and examine their impact on the body’s physiological functions and behaviours.  

The centre, which opens today, will serve as a hub of shared expertise, including the research capabilities of the Johns Hopkins University Center for Metabolism and Obesity Research in the United States and major medical institutions and hospitals in Daegu.

“The Neurometabolomics Excellence Research Center will help sharpen South Korea’s edge in brain science and allow DGIST to contribute significantly to world-leading research,” said the DGIST Research Center Director, Professor Eun-Kyoung Kim. “By working with Agilent, we can continue to spearhead developments and research in brain science.”

The centre, located in Daegu, plans to conduct neurometabolomics research projects involving other fields of studies such as medicine, neurobiology, statistics, computer science and systems biology. There will be potential joint research with major educational and medical institutions elsewhere in South Korea, Singapore and Australia. The centre will also train and develop scientists, researchers and chemists to fill the need for skilled talent in neuroscience research.

Agilent and DGIST have worked together since late 2012, with Agilent providing DGIST with early access to novel technology and software development for its research needs.